💊FDA PHARMA today

By EMA, Pharmaceutical

💊FDA PHARMA today

Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

http://www.kyowa-kirin.com/news_releases/2017/pdf/e20171215_01.pdf

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease

https://www.takeda.com/newsroom/newsreleases/2017/takeda-and-tigenix-announce-that-cx601-darvadstrocel-has-received-a-positive-chmp-opinion-to-treat-complex-perianal-fistulas-in-crohns-disease/

More from tokioX :

  1. Top 50 Global Pharma Companies – 2018 (Pharmaceutical Executive)
  2. 💉FDA PHARMA TODAY
  3. 💊FDA & PHARMA TODAY
  4. FDA PHARMA TODAY
  5. 💊Takeda Announces Intention to Acquire TiGenix
  6. 💊FDA PHARMA today
  7. 💊Pharma – News Releases
,